Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Cervical Neoplasms | 5 | 2022 | 237 | 1.060 |
Why?
|
| Patient Compliance | 1 | 2017 | 470 | 0.450 |
Why?
|
| Radiation Pneumonitis | 1 | 2012 | 13 | 0.420 |
Why?
|
| Protons | 1 | 2012 | 91 | 0.400 |
Why?
|
| Esophageal Neoplasms | 2 | 2012 | 359 | 0.370 |
Why?
|
| Brachytherapy | 3 | 2020 | 74 | 0.360 |
Why?
|
| Chemoradiotherapy | 4 | 2022 | 100 | 0.320 |
Why?
|
| Radiosurgery | 2 | 2020 | 106 | 0.290 |
Why?
|
| Pain, Procedural | 1 | 2020 | 10 | 0.180 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2020 | 34 | 0.170 |
Why?
|
| Anesthesia, Local | 1 | 2020 | 48 | 0.170 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 65 | 0.170 |
Why?
|
| Analgesics | 1 | 2020 | 134 | 0.160 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 46 | 0.150 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2017 | 54 | 0.140 |
Why?
|
| Pneumonectomy | 1 | 2017 | 129 | 0.130 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 858 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 654 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1118 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 1006 | 0.120 |
Why?
|
| Middle Aged | 7 | 2022 | 26087 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 334 | 0.110 |
Why?
|
| Quality of Life | 1 | 2022 | 1933 | 0.100 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2012 | 66 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2020 | 16068 | 0.100 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 135 | 0.100 |
Why?
|
| Multimodal Imaging | 1 | 2012 | 111 | 0.100 |
Why?
|
| Proton Therapy | 1 | 2012 | 123 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2012 | 196 | 0.090 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 291 | 0.090 |
Why?
|
| Age Factors | 1 | 2017 | 2811 | 0.090 |
Why?
|
| Metformin | 1 | 2012 | 147 | 0.090 |
Why?
|
| Female | 9 | 2022 | 65619 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 429 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1591 | 0.070 |
Why?
|
| Aged | 5 | 2020 | 19194 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2022 | 1211 | 0.060 |
Why?
|
| Adult | 5 | 2022 | 29100 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 994 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 6392 | 0.060 |
Why?
|
| Humans | 9 | 2022 | 123258 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2058 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 850 | 0.060 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2022 | 11 | 0.050 |
Why?
|
| Safety-net Providers | 1 | 2022 | 44 | 0.050 |
Why?
|
| Cystoscopy | 1 | 2022 | 44 | 0.050 |
Why?
|
| Urban Population | 1 | 2022 | 220 | 0.050 |
Why?
|
| Promethazine | 1 | 2020 | 5 | 0.040 |
Why?
|
| Hydromorphone | 1 | 2020 | 11 | 0.040 |
Why?
|
| Lorazepam | 1 | 2020 | 12 | 0.040 |
Why?
|
| Organs at Risk | 1 | 2020 | 23 | 0.040 |
Why?
|
| Antiemetics | 1 | 2020 | 23 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2020 | 42 | 0.040 |
Why?
|
| Radiotherapy Dosage | 1 | 2020 | 185 | 0.040 |
Why?
|
| Rectum | 1 | 2020 | 97 | 0.040 |
Why?
|
| Anti-Anxiety Agents | 1 | 2020 | 72 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 361 | 0.040 |
Why?
|
| Radiography | 1 | 2022 | 822 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2020 | 242 | 0.040 |
Why?
|
| Cisplatin | 1 | 2020 | 242 | 0.040 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2018 | 14 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 61 | 0.040 |
Why?
|
| Veterans Health | 1 | 2017 | 174 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1598 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1473 | 0.030 |
Why?
|
| Male | 3 | 2017 | 60336 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 1099 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 6030 | 0.020 |
Why?
|
| Esophagectomy | 1 | 2012 | 60 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1662 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 669 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 3549 | 0.020 |
Why?
|
| Lung | 1 | 2017 | 1465 | 0.020 |
Why?
|
| United States | 1 | 2017 | 10652 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 8868 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 12169 | 0.010 |
Why?
|